Gerald E Marti

Author PubWeight™ 61.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2010 5.95
2 B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 2009 4.27
3 ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003 3.16
4 Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 2007 3.11
5 Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 2010 2.37
6 Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 2010 1.79
7 Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood 2004 1.48
8 Telomere length and heavy-chain mutation status in familial chronic lymphocytic leukemia. Leuk Res 2002 1.44
9 Report from a workshop on multianalyte microsphere assays. Cytometry 2002 1.43
10 A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia. Blood 2007 1.32
11 International Society for Analytical Cytology biosafety standard for sorting of unfixed cells. Cytometry A 2007 1.24
12 Variables affecting the quantitation of CD22 in neoplastic B cells. Cytometry B Clin Cytom 2010 1.21
13 Identification of a novel chromosome region, 13q21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leukemia. Blood 2006 1.19
14 A genome scan of 18 families with chronic lymphocytic leukaemia. Br J Haematol 2003 1.18
15 Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population. Cytometry B Clin Cytom 2007 1.18
16 Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood 2009 1.15
17 Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium. Am J Hematol 2014 1.15
18 Formalization of the MESF unit of fluorescence intensity. Cytometry B Clin Cytom 2004 1.10
19 Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2010 1.09
20 Human CD4+ lymphocytes for antigen quantification: characterization using conventional flow cytometry and mass cytometry. Cytometry A 2012 1.07
21 Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol 2010 1.05
22 Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation. Br J Haematol 2007 1.01
23 Monoclonal B-cell lymphocytosis in blood donors. Br J Haematol 2007 0.97
24 Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding. Blood 2013 0.96
25 Prevalence of monoclonal B-cell lymphocytosis: a systematic review. Cytometry B Clin Cytom 2010 0.92
26 Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Br J Haematol 2007 0.92
27 CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not. Blood 2002 0.91
28 Perspectives on familial chronic lymphocytic leukemia: genes and the environment. Semin Hematol 2004 0.90
29 Overview of monoclonal gammopathies of undetermined significance. Br J Haematol 2007 0.89
30 Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas. European J Clin Med Oncol 2010 0.88
31 High-density mapping and follow-up studies on chromosomal regions 1, 3, 6, 12, 13 and 17 in 28 families with chronic lymphocytic leukaemia. Br J Haematol 2006 0.88
32 Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies. Br J Haematol 2007 0.87
33 Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells. Cytometry B Clin Cytom 2006 0.86
34 Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation. Cytometry B Clin Cytom 2011 0.82
35 Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies. Clin Cancer Res 2004 0.82
36 Variables in the quantification of CD4 in normals and hairy cell leukemia patients. Cytometry B Clin Cytom 2011 0.81
37 Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom 2011 0.80
38 Evolution of a precursor. Cytometry B Clin Cytom 2010 0.79
39 Monoclonal B cell lymphocytosis: clinical and population perspectives. Cytometry B Clin Cytom 2010 0.78
40 Albumin enhanced morphometric image analysis in CLL. Cytometry B Clin Cytom 2004 0.77
41 ATM mutations and protein expression are not associated with familial B-CLL cases. Leuk Res 2003 0.77
42 Bcl-2 level as a biomarker for 13q14 deletion in CLL. Cytometry B Clin Cytom 2013 0.76
43 Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection. Cytometry B Clin Cytom 2010 0.76
44 Combined normal donor and CLL: Single tube ZAP-70 analysis. Cytometry B Clin Cytom 2011 0.75
45 Spontaneous (pathological) splenic rupture in a blastic variant of mantle cell lymphoma: a case report and literature review. Clin Lymphoma 2002 0.75
46 Quantitative detection of zeta-chain-associated protein 70 expression in chronic lymphocytic leukemia. Leuk Lymphoma 2012 0.75
47 Quantification of cells with specific phenotypes I: determination of CD4+ cell count per microliter in reconstituted lyophilized human PBMC prelabeled with anti-CD4 FITC antibody. Cytometry A 2015 0.75
48 Concerning the article by de Carvalho Bittencourt et al.: Value of HIV patients with regular follow-up as in-house internal controls of flow cytometry measurement of lymphocyte subsets. Cytometry B Clin Cytom 2013 0.75
49 Familial lymphoid neoplasms in patients with mantle cell lymphoma. Haematologica 2004 0.75
50 ICSH/ICCS practice guidelines special issue. Cytometry B Clin Cytom 2013 0.75
51 The detection of minimal residual disease status in chronic lymphocytic leukemia. Cytometry B Clin Cytom 2011 0.75
52 B cells behaving badly. Br J Haematol 2007 0.75
53 Introduction to multiple myeloma special issue: The flow cytometric detection of minimal residual disease. Cytometry B Clin Cytom 2016 0.75